Mei Haruya has extensive leadership experience in the pharma industry across R&D, Medical, Corporate Strategy, RWE, Digital Innovation, New Product Planning, Government Affairs, and Market Access. Most recently, he is Corporate Officer, Head of Value & Access at Novartis Japan leading the functions of Pricing & Policy, HEOR, New Product Planning, Population Health Partnerships, and Wholesaler & KAM. He is also a member of International Leadership Team at Novartis Japan. Mei has PhD and MS from the University of Tokyo and MBA from University of Massachusetts.

Career

2022	Corporate Officer, Head, Value & Access, Novartis
2021	Head, Market Access, Policy & New Products, Novartis
2020	Member of Board Director, Japan Association of Vaccine Industries
2019	Director, Government Affairs & Market Access , GSK
2018	Head, Medical Strategy, Medical Japan , GSK
2017	Manager, Strategic Innovation Dept., Japan Development, GSK
2016	President Support, President Office, GSK
2015	Strategy Planning, Corporate Strategy, GSK
2012	Project Manager, Project Management Dept., Japan Development, GSK
2009	Clinical Research Associate , Clinical Monitoring Dept., Japan Development, GSK
2008	Medicinal Chemist, Medicinal Chemistry Dept., Tsukuba Merck Research Laboratories, Banyu Pharma (Merck &Co.)

Education

2015	PhD in Department of Medical Genome Sciences, The University of Tokyo
2008	MS in Department of Chemistry, The University of Tokyo
2023	MBA in University of Massachusetts